Anthelmintic cyclcooctadepsipeptides: complex in structure and mode of action.
about
Research for new drugs for elimination of onchocerciasis in AfricaEfficacy of cyclooctadepsipeptides and aminophenylamidines against larval, immature and mature adult stages of a parasitologically characterized trichurosis model in miceCharacterization of the Ca2+-gated and voltage-dependent K+-channel Slo-1 of nematodes and its interaction with emodepsideDiethylcarbamazine increases activation of voltage-activated potassium (SLO-1) currents in Ascaris suum and potentiates effects of emodepsideMacrocyclic lactones differ in interaction with recombinant P-glycoprotein 9 of the parasitic nematode Cylicocylus elongatus and ketoconazole in a yeast growth assayIn vitro efficacy of cyclooctadepsipepdtides and aminophenylamidines alone and in combination against third-stage larvae and adult worms of Nippostrongylus brasiliensis and first-stage larvae of Trichinella spiralis.Recent advances in candidate-gene and whole-genome approaches to the discovery of anthelmintic resistance markers and the description of drug/receptor interactions.Ion channels and drug transporters as targets for anthelmintics.Genetic blueprint of the zoonotic pathogen Toxocara canis.Heterologous Expression in Remodeled C. elegans: A Platform for Monoaminergic Agonist Identification and Anthelmintic Screening.Fungal natural products in research and development.In vivo efficacy of PF1022A and nicotinic acetylcholine receptor agonists alone and in combination against Nippostrongylus brasiliensis.Structural Diversity and Biological Activities of Cyclic Depsipeptides from Fungi.Brain penetration of emodepside is increased in P-glycoprotein-deficient mice and leads to neurotoxicosis.A BRIEF REVIEW ON THE MODE OF ACTION OF ANTINEMATODAL DRUGS.
P2860
Q28066402-CB5F07A5-8A7C-4B68-859C-D128808ACC89Q28539946-70D3F9B5-3463-4BAD-A4B9-3F7938B1E39EQ28542769-7306FA69-07B8-4BC2-9C44-A2622E6ED4E3Q28545077-A5AF54C6-01D4-4E7D-95D8-CC0260D560CEQ28545804-9AFB9BF1-FB3E-49B2-8EDE-BF8109332C4DQ34439708-F9DBC984-13EE-4391-9D95-97EF9BB2D0C3Q34705912-C1D6727C-ABA6-4EAB-8467-22B846D5E6C4Q34782668-8C2B2403-EA8B-435A-8A0F-FA7DD1FA8B01Q35081761-F72C7DF6-070F-473B-84CE-6F0CF8E8235BQ35557727-BA5095A7-E823-46DB-8240-A61EBF4AE6A5Q38239799-B5EA0BBE-FC24-46BB-89F0-B622AF677DDCQ39150673-3F7C13DF-D842-45C6-BB07-8F11D7B67C3BQ48225314-D12DBB22-9815-470B-BB1B-F5C0FDAE266EQ48599130-A76F5D49-0EEE-472C-B233-496A5A0B2B49Q49401023-8590AA53-EAFE-41FF-ABAD-1645197924E9
P2860
Anthelmintic cyclcooctadepsipeptides: complex in structure and mode of action.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Anthelmintic cyclcooctadepsipeptides: complex in structure and mode of action.
@en
type
label
Anthelmintic cyclcooctadepsipeptides: complex in structure and mode of action.
@en
prefLabel
Anthelmintic cyclcooctadepsipeptides: complex in structure and mode of action.
@en
P2093
P356
P1476
Anthelmintic cyclcooctadepsipeptides: complex in structure and mode of action.
@en
P2093
Achim Harder
Claudia Welz
Lindy Holden-Dye
Peter Jeschke
Vincent O'Connor
P304
P356
10.1016/J.PT.2012.06.005
P577
2012-07-31T00:00:00Z